We reviewed the current knowledge on HER2status in premalignant gastric lesions and in early (EGC) and advanced (AGC) GC to discussthe possible pathogenetic and prognostic roles of HER2 overexpression in GC. This evidence concerns the gene ERBB2 and gastric cancer.